NCT03582033 2024-12-24A Safety Study of SEA-BCMA in Patients With Multiple MyelomaSeagen Inc.Phase 1 Terminated83 enrolled 57 charts
NCT01950364 2016-05-11A Phase 1 Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell LymphomaMillennium Pharmaceuticals, Inc.Phase 1 Completed20 enrolled 59 charts